UniProtKB/Swiss-Prot Q8TAB3: Variant p.Arg958Gln

Protocadherin-19
Gene: PCDH19
Feedback?

Variant information Variant position:

958 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glutamine (Q) at position 958 (R958Q, p.Arg958Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs748581653 [ dbSNP | Ensembl ]

Sequence information Variant position:

958 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1148 The length of the canonical sequence.
Location on the sequence:

SVTSMGSQMPDHDQNEGFHC R EECRILGHSDRCWMPRNPMP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SVTSMGSQMPDHDQNEGFHCREECRILGHSDRCWMPRNPMP

Mouse                         SVTSMGSQMPDHDQNEGFHCREECRILGHSDRCWMPRNPMP

Zebrafish                     TVPSNNSQIPDQDQSEGFHCQDECRILGHSDRCWMPRVPIP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	22 – 1148	Protocadherin-19
Topological domain	700 – 1148	Cytoplasmic

Literature citations
Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families.
Hynes K.; Tarpey P.; Dibbens L.M.; Bayly M.A.; Berkovic S.F.; Smith R.; Raisi Z.A.; Turner S.J.; Brown N.J.; Desai T.D.; Haan E.; Turner G.; Christodoulou J.; Leonard H.; Gill D.; Stratton M.R.; Gecz J.; Scheffer I.E.;
J. Med. Genet. 47:211-216(2010)
Cited for: VARIANTS DEE9 PRO-276 AND LYS-557; VARIANTS GLN-958 AND GLY-1107;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.